Federal TB Task Force
The Federal Tuberculosis (TB) Task Force is a coalition composed of the federal agencies involved in U.S. TB research and control efforts. Established in 1991, it facilitates coordination of activities among these federal agencies. It was established under the leadership of the Director of the Centers for Disease Control and Prevention (CDC) (then William C. Roper, MD) to address the outbreaks of multidrug-resistant (MDR) TB occurring during the 1985–1992 surge in TB cases.
CDC provides leadership for the Federal TB Task Force. Members of CDC senior executive staff have chaired the Task Force since its beginning. Other CDC staff serve on the Task Force, as well.
Activities and Accomplishments
Federal TB Task Force members communicate regularly to discuss TB activities and research.
- Maximizing the Promise of Breakthrough Tuberculosis Test
- By April 1992, the Task Force had developed the National Action Plan to Combat Multidrug-Resistant Tuberculosis.
- In 2003, the team released the Federal TB Task Force Plan in Response to the Institute of Medicine Report, Ending Neglect: The Elimination of Tuberculosis in the United States.
- Members participated in a World Health Organization Global TB Task Force that issued a global plan for responding to extensively drug-resistant (XDR) TB.
- In 2009, the TB Task Force released the Plan to Combat Extensively Drug-Resistant Tuberculosis.
- Agency for Healthcare Research and Quality, DHHS
- Food and Drug Administration, DHHS
- Health Care Financing Administration, DHHS
- Health Resources and Services Administration, DHHS
- Indian Health Service, DHHS
- National Institutes of Health, DHHS
- Office of the Assistant Secretary for Administration and Management/PSC, DHHS
- Substance Abuse and Mental Health Services Administration, DHHS
- Page last reviewed: December 5, 2014
- Page last updated: September 20, 2016
- Content source: